A Double-Blind Placebo-Controlled Randomised Phase 1b Study of the Pharmacokinetics of ALE.F02 in Patients with Advanced Liver Fibrosis and/or with Mild Cirrhosis

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516455-40-00

Acronym

ALE.F02.02

Enrollment

Registered

2024-10-21

Start date

2023-05-25

Completion date

2024-10-29

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced liver fibrosis and/or mild liver cirrhosis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Romania, Slovakia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026